肝衰竭实验室检测的临床价值及新指标评价

聂青和

doi:10.3969/j.issn.1001-5256.2013.09.008

肝衰竭实验室检测的临床价值及新指标评价

DOI: 10.3969/j.issn.1001-5256.2013.09.008

聂青和

第四军医大学唐都医院传染病科、全军感染病诊疗中心

详细信息

中图分类号: R575.3
计量
- 文章访问数: 3512
- HTML全文浏览量: 20
- PDF下载量: 802
- 被引次数: 0
出版历程
- 收稿日期: 2013-04-25
- 出版日期: 2013-09-20

Clinical implications of laboratory tests in liver failure and evaluation of new laboratory indices for liver failure

Nie QingHe

Chinese PLA Centre of Diagnosis and Treatment for Infectious Diseases & Department of Infectious Diseases, Tangdu Hospital, Fourth Military Medical University

摘要

摘要: 肝衰竭的病因及临床类型复杂、并发症较多、病程进展较快、临床干预措施存在多样性,因此很难用单一某项实验室指标来准确地评价肝功能受损的程度及精确地预测肝衰竭的预后。近年来,一些反映肝衰竭预后评价的新的生物标志物、生化指标不断涌现,如何将这些新的指标结合经典的多种肝脏功能实验及生化检测指标纳入判断肝衰竭预测预后指标中,从而不断完善现有的反映肝衰竭病情严重程度和预后判断相关的评分系统和生物指标仍须要进行大量研究工作及临床验证。
- 肝功能衰竭 /
- 实验室技术和方法 /
- 预后
Abstract: As liver failure is associated with a complex etiology, complicated clinical types, a wide range of complications, rapid progression, and varied clinical interventions, it is difficult to use a single laboratory index to accurately evaluate the degree of liver function damage and accurately predict the prognosis of liver failure. With the recent emergence of a variety of novel biomarkers and biochemical indices for assessment of the prognosis of liver failure, extensive research work is needed to study how to combine these new indices with classic liver function tests and biochemical indices for prediction of the prognosis of liver failure. This effort will help to refine the existing scoring system and biomarkers for severity assessment and prognosis prediction of liver failure.
- liver failure /
- laboratory techniques and procedures /
- prognosis

HTML全文

参考文献(18)

[1]LI MD, NIE QH.Current situation and prospect of research on liver failure[J].J Clin Hepatol, 2013, 16 (1) :9-11. (in Chinese) 李梦东, 聂青和.肝衰竭的研究现状与展望[J].实用肝脏病杂志, 2013, 16 (1) :9-11.

[2] Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association;Sever Liver Diseases and Artificial Liver Group, Chinese Society of Hepatology, Chinese Medical Association.Guidelines for the diagnosis and treatment of liver failure (2012 Edition) [J].Chin J Hepatol, 2013, 21 (3) :177-183. (in Chinese) 中华医学会感染病学分会肝衰竭与人工肝学组、中华医学会肝病学分会重型肝病与人工肝学组.肝衰竭诊治指南 (2012年版) [J].中华肝脏病杂志, 2013, 21 (3) :177-183.

[3]LUO XD, NIE QH.Clinical significance of laboratory testing for severe hepatitis[J].J Clin Hepatol, 2004, 7 (1) :7-9. (in Chinese) 罗新栋, 聂青和.重型肝炎实验室检测的临床意义[J].实用肝脏病杂志, 2004, 7 (1) :7-9.

[4]ELINAV E, BEN-DOV I, HAI-AM E, et al.The predictive value of admission and follow up factor V andⅦlevels in patients with acute hepatitis and coagulopathy[J].J Hepatol, 2005, 42 (1) :82-86.

[5]LEE WM.Acute liver failure[J].Semin Respir Crit Care Med, 2012, 33 (1) :36-45.

[6]LEE WM, STRAVITZ RT, LARSON AM.Introduction to the revised American association for the study of liver diseases position paper on acute liver failure 2011[J].Hepatology, 2012, 55 (3) :965-967.

[7]DU WB, PAN XP, LI LJ.Prognostic models for acute liver failure[J].Hepatobiliary Pancreat Dis Int, 2010, 9 (2) :122-128.

[8]RAHMAN SH.Prognostic utility of postoperative C-reative protein for post hepatectomy liver failure[J].Arch Surg, 2008, 143 (3) :247-253.

[9]MERLE U, SIEG O, STREMMEL W, et al.Sensitivity and specificity of plasma disappearance rate of indocyanine green as a prognostic indicator in acute liver failure[J].BMC Gastroenterol, 2009, 3 (9) :91-97.

[10]YAMADA A, HARA T, LI F, et al.Quantitative evaluation of liver function with use of gadoxetate disodium-enhanced MR imaging[J].Radiology, 2011, 260 (3) :727-733.

[11]BERNAL W, DONALDSON N, WYNCOLL D, et al.Blood lactate as an early predictor of outcome in paracetamol-induced acute liver failure:a cohort study[J].Lancet, 2002, 359 (9306) :558-563.

[12]CABAN A, WIADERKIEWICZ R, KAMINSKI M, et al.Arterial ketone index in assessing liver function and its detoxicative capability after ischemia reperfusion injury[J].Acta Biochim Pol, 2000, 47 (4) :1137-1146.

[13]MOLLER HJ, GRONBAEK H, SCHIODT FV, et al.Soluble CD163 from activated macrophages predicts mortality in acute liver failure[J].J Hepatol, 2007, 47 (5) :671-676.

[14]DIAO H, IWABUCHI K, LI L, et al, Osteopontin regulates development and function of invafiant natural killer T cells[J].Proc Natl Acad Sci U S A, 2008, 105 (41) :15884-15889.

[15]RUTHERFORD A, KING LY, HYNAN LS, et al.Development of an accurate index for predicting outcomes of patients with acute liver failure[J].Gastroenterology, 2012, 143 (5) :1237-1243.

[16]SETO WK, LAI CL, YUEN MF.Acute-on-chronic liver failure in chronic hepatitis B[J].J Gastroenterol Hepatol, 2012, 27 (4) :662-669.

[17]NIE QH.Role of endotoxemia in incidence of severe hepatitis[J].J Clin Hepatol, 2004, 7 (1) :5-7. (in Chinese) 聂青和.内毒素血症在重型肝炎发病中的地位[J].实用肝脏病杂志, 2004, 7 (1) :5-7.

[18]NIE QH.Progress in comprehensive treatment of liver failure[J].J Clin Hepatol, 2013, 16 (1) :17-19. (in Chinese) 聂青和.肝衰竭综合治疗进展[J].实用肝脏病杂志, 2013, 16 (1) :17-19.

施引文献

资源附件(0)

访问统计